ArticleAmerican journal of translational research2025

Rabeprazole- and vonoprazan-based dual therapies for H pylori eradication: effective with low side effects, rabeprazole being more cost-effective.

Xiaoran Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.